Insider Transactions in Q3 2025 at Bausch Health Companies Inc. (BHC)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
John Paulson |
BUY
Open market or private purchase
|
Indirect |
86,409
+0.24%
|
$604,863
$7.06 P/Share
|
|
Aug 12
2025
|
John Paulson |
BUY
Open market or private purchase
|
Indirect |
1,156,640
+3.12%
|
$6,939,840
$6.88 P/Share
|
|
Aug 11
2025
|
John Paulson |
BUY
Open market or private purchase
|
Indirect |
2,000,000
+5.44%
|
$12,000,000
$6.35 P/Share
|
|
Jul 25
2025
|
Michael Goettler Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,149
+50.0%
|
-
|
|
Jul 25
2025
|
Sandra Leung Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,149
+50.0%
|
-
|
|
Jul 17
2025
|
Aimee J. Lenar EVP, US Pharma |
BUY
Grant, award, or other acquisition
|
Direct |
30,847
+10.58%
|
-
|
|
Jul 15
2025
|
Aimee J. Lenar EVP, US Pharma |
SELL
Payment of exercise price or tax liability
|
Direct |
22,736
-9.0%
|
$136,416
$6.42 P/Share
|
|
Jul 14
2025
|
Steven Hyosig Lee SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
27,371
+50.0%
|
-
|